The Ashwagandha Plot Bubbles and Thickens

The ashwagandha plot bubbles and thickens, and the crucible now precipitates visible impurity.

The Ashwagandha Standards Alliance applauds NutraIngredients for yesterday’s article by Asia Sherman, which illustrates all together the stark contrast between one popular narrative and the science.

The narrative says that root is authentic, that leaf is suspect, and that the Ministry of Ayush ban is a necessary correction.

But the science says something much different.

And to me, the real issue here is distraction without full disclosure — on multiple levels.

—–

First, we have those who drive the narrative, claiming that integrity is everything. If that’s so, then why is no one able to verify the composition of their products as they are labeled?

When a supplier states ‘root-only’, what does that really mean?

What are the individual compounds which comprise “total withanolides” printed on millions of product labels worldwide containing that ingredient?

If no one can answer these questions, then that’s the larger problem underneath, bubbling to the surface here.

—–

We also have those who are silently caught in a web. Like those whose science and safety was not on root-only material as previously disclosed — but actually on root+leaf.

This means much of the evidence previously thought root-only actually belongs in the root-and-leaf category.

It also means that consumption of root-and-leaf is much more widespread than previously thought.

And it means that literature used by the Ministry to generate its conclusions has been misclassified, while the misguided claim that root-and-leaf lacks sufficient evidence becomes much weaker.

How many clinicals and safety studies on root-and-leaf is good enough? Does 30+ sound like enough?

—–

Ultimately, whether leaf is added to root or not, the science suggests that the plant-part hullaballoo may be a red herring when it comes to safety.

Thanks to recent published reviews by Thomas Brendler and colleagues, the adverse-event record does not establish causality by either plant part.

And as Mark Blumenthal noted: properly labeled leaf-containing products are not adulterated simply because they contain leaf. As much as the “root-good-leaf-bad” folks would like us to think, there’s no evidence that the leaf is unsafe.

The picture outside of the crucible is actually simple and clear.

We need plant-part disclosure, better identity testing, validated analytical methods, adequately labeled products.

And all of that — not just the parts that people want us to see.

Because these are simple, basic GMP’s which no amount of influence will change.

Article link: https://www.nutraingredients.com/Article/2026/04/28/india-bans-ashwagandha-leaf-use-in-any-form-industry-reacts/